Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Treatment Study of ACH-0144471 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) With Inadequate Response to Eculizumab (PNH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03472885
Recruitment Status : Active, not recruiting
First Posted : March 21, 2018
Last Update Posted : August 20, 2019
Sponsor:
Information provided by (Responsible Party):
Achillion Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 30, 2019
Estimated Study Completion Date : December 31, 2020